A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs

被引:28
作者
Eguchi, Takanori [1 ,2 ]
Taha, Eman Ahmed [1 ,3 ,4 ]
Calderwood, Stuart K. [5 ]
Ono, Kisho [6 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama 7008525, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan
[3] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med Bioengn, Okayama 7008530, Japan
[4] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo 11566, Egypt
[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA
[6] Okayama Univ Hosp, Dept Oral & Maxillofacial Surg, Okayama 7000914, Japan
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 03期
关键词
extracellular vesicle (EV); exosome; oncosome; drug resistance; epithelial-mesenchymal transition (EMT); heat shock protein (HSP); cell stress response; resistance-associated secretory phenotype (RASP); hypoxia; acidosis; tumor immunology; HEAT-SHOCK PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLES; TUMOR MICROENVIRONMENT; P-GLYCOPROTEIN; BREAST-CANCER; STEM-CELLS; MICROVESICLES PROMOTE; INDUCE APOPTOSIS; MEDIATE TRANSFER;
D O I
10.3390/biology9030047
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Extracellular vesicles (EVs), such as exosomes or oncosomes, often carry oncogenic molecules derived from tumor cells. In addition, accumulating evidence indicates that tumor cells can eject anti-cancer drugs such as chemotherapeutics and targeted drugs within EVs, a novel mechanism of drug resistance. The EV-releasing drug resistance phenotype is often coupled with cellular dedifferentiation and transformation in cells undergoing epithelial-mesenchymal transition (EMT), and the adoption of a cancer stem cell phenotype. The release of EVs is also involved in immunosuppression. Herein, we address different aspects by which EVs modulate the tumor microenvironment to become resistant to anticancer and antibody-based drugs, as well as the concept of the resistance-associated secretory phenotype (RASP).
引用
收藏
页数:22
相关论文
共 193 条
  • [51] Autophagy and multivesicular bodies: two closely related partners
    Fader, C. M.
    Colombo, M. I.
    [J]. CELL DEATH AND DIFFERENTIATION, 2009, 16 (01) : 70 - 78
  • [52] Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
    Faict, Sylvia
    Muller, Josephine
    De Veirman, Kim
    De Bruyne, Elke
    Maes, Ken
    Vrancken, Louise
    Heusschen, Roy
    De Raeve, Hendrik
    Schots, Rik
    Vanderkerken, Karin
    Caers, Jo
    Menu, Eline
    [J]. BLOOD CANCER JOURNAL, 2018, 8
  • [53] Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
    Federici, Cristina
    Petrucci, Francesco
    Caimi, Stefano
    Cesolini, Albino
    Logozzi, Mariantonia
    Borghi, Martina
    D'Ilio, Sonia
    Lugini, Luana
    Violante, Nicola
    Azzarito, Tommaso
    Majorani, Costanza
    Brambilla, Daria
    Fais, Stefano
    [J]. PLOS ONE, 2014, 9 (02):
  • [54] Metabolic reprogramming of the tumor
    Ferreira, L. M. R.
    Hebrant, A.
    Dumont, J. E.
    [J]. ONCOGENE, 2012, 31 (36) : 3999 - 4011
  • [55] Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
    Franzen, C. A.
    Blackwell, R. H.
    Todorovic, V.
    Greco, K. A.
    Foreman, K. E.
    Flanigan, R. C.
    Kuo, P. C.
    Gupta, G. N.
    [J]. ONCOGENESIS, 2015, 4 : e163 - e163
  • [56] Extracellular vesicle transfer of cancer pathogenic components
    Fujita, Yu
    Yoshioka, Yusuke
    Ochiya, Takahiro
    [J]. CANCER SCIENCE, 2016, 107 (04) : 385 - 390
  • [57] Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab
    Fujiwara, Toshifumi
    Eguchi, Takanori
    Sogawa, Chiharu
    Ono, Kisho
    Murakami, Jun
    Ibaragi, Soichiro
    Asaumi, Jun-ichi
    Calderwood, Stuart K.
    Okamoto, Kuniaki
    Kozaki, Ken-ichi
    [J]. ORAL ONCOLOGY, 2018, 86 : 251 - 257
  • [58] Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition
    Fujiwara, Toshifumi
    Eguchi, Takanori
    Sogawa, Chiharu
    Ono, Kisho
    Murakami, Jun
    Ibaragi, Soichiro
    Asaumi, Jun-ichi
    Okamoto, Kuniaki
    Calderwood, Stuart K.
    Kozaki, Ken-ichi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1267 - 1272
  • [59] TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
    Fuxe, Jonas
    Karlsson, Mikael C. I.
    [J]. SEMINARS IN CANCER BIOLOGY, 2012, 22 (5-6) : 455 - 461
  • [60] Coordinated regulation of myeloid cells by tumours
    Gabrilovich, Dmitry I.
    Ostrand-Rosenberg, Suzanne
    Bronte, Vincenzo
    [J]. NATURE REVIEWS IMMUNOLOGY, 2012, 12 (04) : 253 - 268